Skip to content
Triangle logo TriangleGet started
← Back to this collection

PUBLICATIONS · 35857659

Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Open original source → · Download preserved record

Bibliographic metadata only. No full-text article or abstract is reproduced. Absence of a captured notice is not confirmation that a publication is clear of corrections or retractions.

Journal
N Engl J Med
Publication date
2022 Jul 21
First author
Cortes J

Publication notices

absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Jul 21;387(3):273-274. doi: 10.1056/NEJMe2207532.
    note
    Source null
    related pmid
    35857664
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Oct 13;387(15):1435. doi: 10.1056/NEJMc2210919.
    note
    Source null
    related pmid
    36239656
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Oct 13;387(15):1435-1436. doi: 10.1056/NEJMc2210919.
    note
    Source null
    related pmid
    36239657
    relationship
    Comment in

Authors and identifiers

  1. name
    Cortes J
    type
    Author
  2. name
    Rugo HS
    type
    Author
  3. name
    Cescon DW
    type
    Author
  4. name
    Im SA
    type
    Author
  5. name
    Yusof MM
    type
    Author
  6. name
    Gallardo C
    type
    Author
  7. name
    Lipatov O
    type
    Author
  8. name
    Barrios CH
    type
    Author
  9. name
    Perez-Garcia J
    type
    Author
  10. name
    Iwata H
    type
    Author
  11. name
    Masuda N
    type
    Author
  12. name
    Torregroza Otero M
    type
    Author
Complete bibliographic record and source provenance
authors
  1. name
    Cortes J
    type
    Author
  2. name
    Rugo HS
    type
    Author
  3. name
    Cescon DW
    type
    Author
  4. name
    Im SA
    type
    Author
  5. name
    Yusof MM
    type
    Author
  6. name
    Gallardo C
    type
    Author
  7. name
    Lipatov O
    type
    Author
  8. name
    Barrios CH
    type
    Author
  9. name
    Perez-Garcia J
    type
    Author
  10. name
    Iwata H
    type
    Author
  11. name
    Masuda N
    type
    Author
  12. name
    Torregroza Otero M
    type
    Author
bibliography ids
  1. nci-bib-d9e39b4840cde41e96857922
book metadata
content sha256
9dceb18f44d77cb19062e0c22fb7d1de45d3c58da66aa0eb3116270d973c02be
document type
citation
dois
  1. 10.1056/NEJMoa2202809
electronic publication date
display
Source null
precision
missing
year
Source null
evidence scope
bibliographic_metadata_only
id
pubmed:35857659
immutable id
pubmed:35857659@9dceb18f44d77cb19062e0c22fb7d1de45d3c58da66aa0eb3116270d973c02be
journal
abbreviation
N Engl J Med
issn electronic
1533-4406
issn print
0028-4793
issue
3
name
The New England journal of medicine
nlm unique id
0255562
pages
217-226
volume
387
languages
  1. eng
notices
absence is not clearance
true
has correction metadata
false
has expression of concern metadata
false
has retraction in link
false
pubmed marks article retracted
false
pubmed marks retraction notice
false
relationships
  1. citation
    N Engl J Med. 2022 Jul 21;387(3):273-274. doi: 10.1056/NEJMe2207532.
    note
    Source null
    related pmid
    35857664
    relationship
    Comment in
  2. citation
    N Engl J Med. 2022 Oct 13;387(15):1435. doi: 10.1056/NEJMc2210919.
    note
    Source null
    related pmid
    36239656
    relationship
    Comment in
  3. citation
    N Engl J Med. 2022 Oct 13;387(15):1435-1436. doi: 10.1056/NEJMc2210919.
    note
    Source null
    related pmid
    36239657
    relationship
    Comment in
outcomes validated
false
pmid
35857659
provenance
batch id
9d150d55960e0c12aada
provider
NCBI PubMed ESummary
record sha256
ca07ca5a7e34b6ce0dee113e937e4e6d8e8223263d90fc711d30c04a8f001039
response sha256
2d4ef1cc8137eef6e7216f66bf8601c3899bc663b8626f412794d39585de6b6b
retrieved at
2026-09-09T23:48:09.820498+00:00
publication date
display
2022 Jul 21
precision
day
year
2022
publication types
  1. Clinical Trial, Phase III
  2. Journal Article
  3. Randomized Controlled Trial
record status
PubMed - indexed for MEDLINE
schema version
1.0
source url
https://pubmed.ncbi.nlm.nih.gov/35857659/
title
Pembrolizumab plus Chemotherapy in Advanced Triple-Negative Breast Cancer.

Preserved source evidence · Not medical advice